Results 121 to 130 of about 25,524 (191)

Baloxavir-Based Combination Therapy for Protection against Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Mice. [PDF]

Emerg Infect Dis
Min SC, Lee JR, Kim BK, Park JH, Lee DG, Lee GC, An SH, Chokkakula S, Jain A, Choi YK, Baek YH, Song MS.   +11 more
europepmc   +1 more source

Effectiveness of Oseltamivir in Hospitalized Children With Laboratory-Confirmed Influenza, 2014-2023.

JAMA Pediatr
Rytlewski K, Dunn A, O'Halloran A, Habeck J, Armistead I, Alden NB, Sachdev D, Daily Kirley P, Meek J, Yousey-Hindes K, Kamidani S, Openo KP, Ryan PA, Monroe M, Kim S, Urlaub E, Lynfield R, McMahon M, Smelser CB, Shaw Y, Barney G, Rowlands JV, Tesini B, Felsen C, Lung K, Sutton M, Thomas A, Talbot HK, Schaffner W, George A, Staten H, Cataldi JR, Dominguez SR, Bozio CH, Rao S.   +34 more
europepmc   +1 more source

A randomised, open-label clinical study on the efficacy of baloxavir marboxil and oseltamivir for post-exposure prevention of influenza in a hospital setting: a study protocol. [PDF]

BMJ Open
Li X, Chu Z, Peng M, Yan K, Guan Y, Yang C, Xu J, Qiu L, Liu T.   +8 more
europepmc   +1 more source

Study protocol for a phase II clinical trial evaluating the safety and efficacy of favipiravir injection combined with oseltamivir in influenza treatment. [PDF]

BMJ Open
Hikida S, Nomoto H, Uemura Y, Suzuki T, Izumikawa K, Ohge H, Yamato M, Kato Y, Hase R, Aoyagi T, Hagiya H, Nukui Y, Yamamoto K, Takesue Y, Sawada K, Shimizu Y, Miyamoto S, Tamura N, Takahashi K, Saito S, Miyazaki K, Morino E, Tokita D, Ohmagari N.   +23 more
europepmc   +1 more source

Oseltamivir Resistance in Human Influenza A(H5N1) and A(H7N9) Infections: A Mini Review. [PDF]

Open Forum Infect Dis
Abed Y, Boivin G.
europepmc   +1 more source

Preclinical characterization of HEC116094, an oral inhibitor of the influenza A virus polymerase PB2 subunit. [PDF]

Emerg Microbes Infect
Nie L, Chen Y, Wang P, Xie Y, Zuo Y, Zhang Y, Gu B, Lin K, Li J, Zhang L.   +9 more
europepmc   +1 more source

Transient Platelet Elevation Following Oseltamivir Administration in Pediatric Chronic Immune Thrombocytopenia. [PDF]

Cureus
Yamamoto S, Furui Y, Okura E, Sakamoto K, Hirabayashi K, Saito S, Nakazawa Y.   +6 more
europepmc   +1 more source

Intensive Chemoprophylaxis for Nursing Home Influenza Outbreaks-Reply. [PDF]

JAMA Intern Med
Zullo AR, Silva JBB, Gravenstein S.
europepmc   +1 more source

Oseltamivir drug-disease modelling in infants with influenza virus infection. [PDF]

Br J Clin Pharmacol
Wang K, Kimberlin DW, Whitley RJ, Acosta EP, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.   +4 more
europepmc   +1 more source